Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07258017Not ApplicableCompleted

Impact of Interactive Video Health Intervention on Quality of Life After Bowel Obstruction Surgery

Role: lead

NCT07115459Not Yet Recruiting

Development and Validation of a Prognostic Model for Neurocritical Patients Using Multimodal Brain Monitoring

Role: collaborator

NCT07003191Active Not Recruiting

Metformin Hydrochloride and Empagliflozin Tablets in the Treatment of Type 2 Diabetes

Role: collaborator

NCT02094638Completed

Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study

Role: collaborator

All 4 trials loaded